Patents by Inventor Alain Marty

Alain Marty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180044653
    Abstract: The invention relates to a method for obtaining a mutant oleaginous yeast strain capable of growing on cellobiose as carbon source, comprising overexpressing in said strain two ?-glucosidase enzymes further comprising a N-terminal signal peptide. The invention also relates to a mutant yeast strain obtained by said method.
    Type: Application
    Filed: April 22, 2016
    Publication date: February 15, 2018
    Inventors: Alain Marty, Zhongpeng Guo, Sophie Duquesne, Sophie Bozonnet, Jean-Marc Nicaud, Michael O'Donohue
  • Publication number: 20170313998
    Abstract: The present invention relates to a new isolated polypeptide comprising an amino acid sequence having at least 94%, 95%, 99% or 100% identity to the full length amino acid sequence set forth in SEQ ID NO: 1, and having a polyester degrading activity, and uses thereof.
    Type: Application
    Filed: October 20, 2015
    Publication date: November 2, 2017
    Applicants: CARBIOS, INSTITUT NATIONAL DE LA RECHERCHE AGRONONIQUE, INSTITUT NATIONAL DES SCIENCES APPLIQUEES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: PABLO ALVAREZ, EMILIE AMILLASTRE, SOPHIE DUQUESNE, ALAIN MARTY
  • Publication number: 20160097066
    Abstract: The present invention relates to a method for obtaining a mutant strain of oleaginous yeast which is useful as a template strain of yeast for obtaining other mutant strains of oleaginous yeast which are capable of producing an unusual fatty acid. The present invention also relates to the mutant strains of yeast obtained by said method.
    Type: Application
    Filed: April 30, 2014
    Publication date: April 7, 2016
    Applicant: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
    Inventors: Jean-Marc NICAUD, Alain MARTY, Athanasios BEOPOULOS, Jonathan VERBEKE, Florence BORDES, Marie GUICHERD
  • Patent number: 8834867
    Abstract: Method for producing Yarrowia lipolytica acid-resistant recombinant lipase utilizing a culture medium without any products of animal origin or non-characterized mixtures such as tryptone, peptone or lactoserum, in addition to its uses. Recombinant strain of Yarrow lipolytica producing an excessive amount of lipase Lip2 referred to as YL-LIP2-6C and filed with the Collection Nationale de Cultures de Microorganismes (C.N.C.M.) under number I 3542, on Dec. 15, 2005 and its uses.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: September 16, 2014
    Assignee: Laboratoires Mayoly Spindler
    Inventors: Yves Leblond, Nicolas Mouz, Alain Marty, Jean-Louis Uribelarrea
  • Publication number: 20130052180
    Abstract: Method for producing Yarrowia lipolytica acid-resistant recombinant lipase utilizing a culture medium without any products of animal origin or non-characterized mixtures such as tryptone, peptone or lactoserum, in addition to its uses. Recombinant strain of Yarrow lipolytica producing an excessive amount of lipase Lip2 referred to as YL-LIP2-6C and filed with the Collection Nationale de Cultures de Microorganismes (C.N.C.M.) under number I 3542, on Dec. 15 2005 and its uses.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 28, 2013
    Applicant: LABORATOIRES MAYOLY SPINDLER
    Inventors: Yves Leblond, Nicolas Mouz, Alain Marty, Jean-Louis Uribelarrea
  • Patent number: 8334130
    Abstract: Method for producing Yarrowia lipolytica acid-resistant recombinant lipase utilizing a culture medium without any products of animal origin or non-characterized mixtures such as tryptone, peptone or lactoserum, in addition to its uses. Recombinant strain of Yarrow lipolytica producing an excessive amount of lipase Lip2 referred to as YL-LIP2-6C and filed with the Collection Nationale de Cultures de Microorganismes (C.N.C.M.) under number I 3542, on Dec. 15 2005 and its uses.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: December 18, 2012
    Assignee: Laboratoires Mayoly Spindler
    Inventors: Yves Leblond, Nicolas Mouz, Alain Marty, Jean-Louis Uribelarrea
  • Patent number: 8227479
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Grant
    Filed: June 13, 2011
    Date of Patent: July 24, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Frédérique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • Publication number: 20120003716
    Abstract: Method for producing Yarrowia lipolytica acid-resistant recombinant lipase utilizing a culture medium without any products of animal origin or non-characterized mixtures such as tryptone, peptone or lactoserum, in addition to its uses. Recombinant strain of Yarrow lipolytica producing an excessive amount of lipase Lip2 referred to as YL-LIP2-6C and filed with the Collection Nationale de Cultures de Microorganismes (C.N.C.M.) under number I 3542, on Dec. 15, 2005 and its uses.
    Type: Application
    Filed: June 15, 2006
    Publication date: January 5, 2012
    Applicant: LABORATOIRES MAYOLY SPINDLER
    Inventors: Yves Leblond, Nicolas Mouz, Alain Marty, Jean-Louis Uribelarrea
  • Patent number: 8034377
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 11, 2011
    Assignee: Pierre Fabre Medicament
    Inventors: Frederique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • Publication number: 20110237613
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Application
    Filed: June 13, 2011
    Publication date: September 29, 2011
    Inventors: Frédérique BRUNE, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • Publication number: 20090312354
    Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
    Type: Application
    Filed: June 22, 2007
    Publication date: December 17, 2009
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Frédérique Brune, André Delhon, Jean Gardette, Jean François Patoiseau, Alain Marty, Etienne Severac
  • Patent number: 6217614
    Abstract: The present invention concerns a process for treating bone tissue of animal or human origin, and a corresponding implantable biomaterial. According to the present invention, a fluid in the supercritical state is caused to penetrate throughout the bone tissue. The bone tissue thus treated can then undergo stages of extracting specific proteins. This tissue is intended to be placed on a damaged bone tissue and has mechanical properties at least equivalent to those of natural bone.
    Type: Grant
    Filed: January 16, 1998
    Date of Patent: April 17, 2001
    Assignee: Bioland
    Inventors: Jacques Fages, Alain Marty, Didier Combes, Jean-Stéphane Condoret
  • Patent number: 5725579
    Abstract: The present invention concerns a process for treating bone tissue of animal or human origin, and a corresponding implantable biomaterial. According to the present invention, a fluid in the supercritical state is caused to penetrate throughout the bone tissue. The bone tissue thus treated can then undergo stages of extracting specific proteins. This tissue is intended to be placed on a damaged bone tissue and has mechanical properties at least equivalent to those of natural bone.
    Type: Grant
    Filed: December 6, 1995
    Date of Patent: March 10, 1998
    Assignee: Bioland
    Inventors: Jacques Fages, Alain Marty, Didier Combes, Jean-Stephane Condoret
  • Patent number: 5522228
    Abstract: The invention relates especially to a process for the production of cold, comprising at least one stage of adsorption of carbon dioxide by an adsorbent solid substance and at least one stage of desorption of the carbon dioxide adsorbed in the said adsorbent substance, in which the said adsorbent substance comprises activated carbon fibers or an active charcoal and has a specific surface of at least 700 m.sup.2 /g and an external specific surface of at least 0.005 m.sup.2 /g.
    Type: Grant
    Filed: July 28, 1994
    Date of Patent: June 4, 1996
    Assignee: Manufactures de Vetements Paul Boye S.A.
    Inventors: Andre Guillot, Alain Marty, Patrice Pelletier, Bernard Spinner, Philippe Boye